FDA — authorised 14 September 2018
- Marketing authorisation holder: TEVA PHARMS USA
- Status: approved
🇺🇸 Ajovy in United States
FDA authorised Ajovy on 14 September 2018
Marketing authorisations
FDA — authorised 24 September 2021
- Application: BLA761089
- Marketing authorisation holder: TEVA PHARMS USA
- Indication: Labeling
- Status: approved
Ajovy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Ajovy approved in United States?
Yes. FDA authorised it on 14 September 2018; FDA authorised it on 24 September 2021.
Who is the marketing authorisation holder for Ajovy in United States?
TEVA PHARMS USA holds the US marketing authorisation.